124 related articles for article (PubMed ID: 23896060)
21. Abnormal mRNA Expression Levels of Telomere-Binding Proteins Represent Biomarkers in Myelodysplastic Syndromes: A Case-Control Study.
Liu B; Yan R; Zhang J; Wang B; Sun H; Cui X
Turk J Haematol; 2017 Aug; 34(3):200-206. PubMed ID: 28404540
[TBL] [Abstract][Full Text] [Related]
22. Telomerase activity in myelodysplastic syndromes.
Gürkan E; Tanriverdi K; Başlamişli F
Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
[TBL] [Abstract][Full Text] [Related]
23. Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita.
Kirschner M; Vieri M; Kricheldorf K; Ferreira MSV; Wlodarski MW; Schwarz M; Balabanov S; Rolles B; Isfort S; Koschmieder S; Höchsmann B; Panse J; Brümmendorf TH; Beier F
Br J Haematol; 2021 May; 193(3):669-673. PubMed ID: 32744739
[TBL] [Abstract][Full Text] [Related]
24. Cancer spectrum and outcomes in the Mendelian short telomere syndromes.
Schratz KE; Haley L; Danoff SK; Blackford AL; DeZern AE; Gocke CD; Duffield AS; Armanios M
Blood; 2020 May; 135(22):1946-1956. PubMed ID: 32076714
[TBL] [Abstract][Full Text] [Related]
25. Telomerase activity is required for the telomere G-overhang structure in Trypanosoma brucei.
Sandhu R; Li B
Sci Rep; 2017 Nov; 7(1):15983. PubMed ID: 29167542
[TBL] [Abstract][Full Text] [Related]
26. Short telomere length and its correlation with gene mutations in myelodysplastic syndrome.
Hwang SM; Kim SY; Kim JA; Park HS; Park SN; Im K; Kim K; Kim SM; Lee DS
J Hematol Oncol; 2016 Jul; 9(1):62. PubMed ID: 27465399
[TBL] [Abstract][Full Text] [Related]
27. Telomeric overhang length determines structural dynamics and accessibility to telomerase and ALT-associated proteins.
Hwang H; Kreig A; Calvert J; Lormand J; Kwon Y; Daley JM; Sung P; Opresko PL; Myong S
Structure; 2014 Jun; 22(6):842-53. PubMed ID: 24836024
[TBL] [Abstract][Full Text] [Related]
28. Increase of telomerase activity and hTERT expression in myelodysplastic syndromes.
Briatore F; Barrera G; Pizzimenti S; Toaldo C; Casa CD; Laurora S; Pettazzoni P; Dianzani MU; Ferrero D
Cancer Biol Ther; 2009 May; 8(10):883-9. PubMed ID: 19270495
[TBL] [Abstract][Full Text] [Related]
29. Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a Chinese population.
Dai J; Cai H; Zhuang Y; Wu Y; Min H; Li J; Shi Y; Gao Q; Yi L
Respirology; 2015 Jan; 20(1):122-8. PubMed ID: 25346280
[TBL] [Abstract][Full Text] [Related]
30. Telomere 3' overhang and disease.
Gu BW; Mason P
Leuk Lymphoma; 2013 Jul; 54(7):1347-8. PubMed ID: 23343176
[No Abstract] [Full Text] [Related]
31. Telomere length in myelodysplastic syndromes.
Rollison DE; Epling-Burnette PK; Park JY; Lee JH; Park H; Jonathan K; Cole AL; Painter JS; Guerrier M; Meléndez-Santiago J; Fulp W; Komrokji R; Lancet J; List AF
Leuk Lymphoma; 2011 Aug; 52(8):1528-36. PubMed ID: 21635204
[TBL] [Abstract][Full Text] [Related]
32. Lack of mutations of the human telomerase RNA gene (hTERC) in myelodysplastic syndrome.
Ohyashiki K; Shay JW; Ohyashiki JH
Haematologica; 2005 May; 90(5):691. PubMed ID: 15921388
[TBL] [Abstract][Full Text] [Related]
33. Generation of telomeric G strand overhangs involves both G and C strand cleavage.
Jacob NK; Kirk KE; Price CM
Mol Cell; 2003 Apr; 11(4):1021-32. PubMed ID: 12718887
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of Genetic Aberration and Shorter Telomere Length in Myelodysplastic Syndrome: A Pilot Study.
Park HS; Son BR; Kwon J
Lab Med; 2023 Mar; 54(2):199-205. PubMed ID: 36125233
[TBL] [Abstract][Full Text] [Related]
35. Telomerase activation induces elongation of the telomeric single-stranded overhang, but does not prevent chromosome aberrations in human vascular endothelial cells.
Anno K; Hayashi A; Takahashi T; Mitsui Y; Ide T; Tahara H
Biochem Biophys Res Commun; 2007 Feb; 353(4):926-32. PubMed ID: 17207773
[TBL] [Abstract][Full Text] [Related]
36. Cancer and myeloid clonal evolution in the short telomere syndromes.
Schratz KE; Armanios M
Curr Opin Genet Dev; 2020 Feb; 60():112-118. PubMed ID: 32276199
[TBL] [Abstract][Full Text] [Related]
37. Serum ferritin is an independent prognostic factor in Chinese with myelodysplastic syndromes classified as IPSS Intermediate-1.
Li B; Xu Z; Gale RP; Qin T; Zhang Y; Xiao Z
Acta Haematol; 2013; 129(4):243-50. PubMed ID: 23328695
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.
Zhao X; Tian X; Kajigaya S; Cantilena CR; Strickland S; Savani BN; Mohan S; Feng X; Keyvanfar K; Dunavin N; Townsley DM; Dumitriu B; Battiwalla M; Rezvani K; Young NS; Barrett AJ; Ito S
Br J Haematol; 2016 Nov; 175(3):427-439. PubMed ID: 27433923
[TBL] [Abstract][Full Text] [Related]
39. The clinical and functional effects of TERT variants in myelodysplastic syndrome.
Reilly CR; Myllymäki M; Redd R; Padmanaban S; Karunakaran D; Tesmer V; Tsai FD; Gibson CJ; Rana HQ; Zhong L; Saber W; Spellman SR; Hu ZH; Orr EH; Chen MM; De Vivo I; DeAngelo DJ; Cutler C; Antin JH; Neuberg D; Garber JE; Nandakumar J; Agarwal S; Lindsley RC
Blood; 2021 Sep; 138(10):898-911. PubMed ID: 34019641
[TBL] [Abstract][Full Text] [Related]
40. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups.
Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S
Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
